Yiping W Han

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Topics

Patients With Inflammatory Bowel Disease

Epithelial Mesenchymal Transition

Risk Assessment

Candida Albicans

Top Venues

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jung Eun Baik, Li Li, Manish A Shah, Daniel E Freedberg, Zhezhen Jin, Timothy C Wang, Yiping W Han
Circulating IgA Antibodies Against Fusobacterium nucleatum Amyloid Adhesin FadA are a Potential Biomarker for Colorectal Neoplasia. Cancer research communications 2 (11) (2022)
Jung Eun Baik, Li Li, Manish A Shah, Daniel E Freedberg, Zhezhen Jin, Timothy C Wang, Yiping W Han
Circulating IgA Antibodies Against Fusobacterium nucleatum Amyloid Adhesin FadA are a Potential Biomarker for Colorectal Neoplasia. Cancer research communications 2 (11) (2022)
Qing Meng, Qiuqiang Gao, Shebli Mehrazarin, Kamonchanok Tangwanichgapong, Yu Wang, Yiming Huang, Yutong Pan, Samuel Robinson, Ziwen Liu, Amirali Zangiabadi, Renate Lux, Panos N Papapanou, X Edward Guo, Harris Wang, Luke E Berchowitz, Yiping W Han
Fusobacterium nucleatum secretes amyloid-like FadA to enhance pathogenicity. EMBO reports 22 (7) (2021)
Miles Richardson, Jihui Ren, Mara Roxana Rubinstein, Jamila A Taylor, Richard A Friedman, Bo Shen, Yiping W Han
Analysis of 16S rRNA genes reveals reduced Fusobacterial community diversity when translocating from saliva to GI sites. Gut microbes 12 (1) (2021)
Mara Roxana Rubinstein, Jung Eun Baik, Stephen M Lagana, Richard P Han, William J Raab, Debashis Sahoo, Piero Dalerba, Timothy C Wang, Yiping W Han
Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1. EMBO reports 20 (4) (2019)